SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-15-076292
Filing Date
2015-11-05
Accepted
2015-11-05 16:59:43
Documents
13
Period of Report
2015-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a15-17980_110q.htm 10-Q 718327
2 EX-10.1 a15-17980_1ex10d1.htm EX-10.1 56891
3 EX-31.1 a15-17980_1ex31d1.htm EX-31.1 10682
4 EX-31.2 a15-17980_1ex31d2.htm EX-31.2 10793
5 EX-32.1 a15-17980_1ex32d1.htm EX-32.1 8311
12 GRAPHIC g179801gai001.jpg GRAPHIC 9707
13 GRAPHIC g179801gai002.jpg GRAPHIC 43881
  Complete submission text file 0001104659-15-076292.txt   3920044

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT snta-20150930.xml EX-101.INS 811729
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20150930.xsd EX-101.SCH 30787
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20150930_cal.xml EX-101.CAL 37451
9 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20150930_lab.xml EX-101.LAB 329299
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20150930_pre.xml EX-101.PRE 217346
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20150930_def.xml EX-101.DEF 112420
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 151201469
SIC: 2834 Pharmaceutical Preparations